What’s the current market cap for Spire Healthcare Group stock?

Spire Healthcare Group (SPI) has a market cap of £871m as of June 10, 2026.

What is the P/E ratio for Spire Healthcare Group stock?

The price to earnings (P/E) ratio for Spire Healthcare Group (SPI) stock is 54.44 as of June 10, 2026.

Does Spire Healthcare Group stock pay dividends?

Yes, the Spire Healthcare Group (SPI) stock pays dividends to shareholders. As of June 10, 2026, the dividend rate is £0.023 and the yield is 1.06%. Spire Healthcare Group has a payout ratio of 56.1% on a trailing twelve-month basis.

When is the next Spire Healthcare Group dividend payment date?

The next Spire Healthcare Group (SPI) dividend payment is scheduled for June 19, 2026.

What is the beta indicator for Spire Healthcare Group?

Spire Healthcare Group (SPI) has a beta rating of 0.91. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy Spire Healthcare Group stock | £SPI Share Price

07:00

09:10

11:15

13:25

15:30

About Spire Healthcare Group

Spire Healthcare Group PLC, listed under the ticker SPI, is a prominent provider of private healthcare in the United Kingdom. The company operates a network of private hospitals and clinics offering comprehensive treatment options spanning various medical fields. Founded in 2007, Spire Healthcare has established a reputation for clinical excellence and responsive patient care.

Ticker

£SPI

Sector

Health

Primary listing

LSE

Employees

17,800

Headquarters

London, United Kingdom

Website

www.spirehealthcare.com

SPI Metrics

BasicAdvanced

£871m

54.44

£0.04

0.91

£0.02

1.06%

What the Analysts think about SPI

Analyst ratings (Buy, Hold, Sell) for Spire Healthcare Group stock.

Bulls say / Bears say

London’s Spire Healthcare received an unsolicited $1.35 billion buyout proposal from Toscafund, underscoring that the company may be undervalued and could command a takeover premium. (Reuters)

The company has started an early-stage strategic review with Rothschild & Co, looking at options such as a sale, demonstrating that management is proactively seeking to unlock shareholder value. (Reuters)

Spire confirmed initial discussions with private equity groups Bridgepoint and Triton, signaling strong interest from the market that could lead to a profitable exit for investors. (Reuters)

Spire warned that adjusted profit for FY25 will be at the low end of guidance, citing a slowdown in NHS commissioning and highlighting challenges in public sector revenues. (Reuters)

FY25 adjusted EBITDA missed market expectations despite revenues meeting forecasts, showing ongoing margin pressure from rising costs. (Reuters)

Shares dropped by up to 21%, reaching their lowest point since March 2021, after preliminary strategic talks ended, highlighting investor uncertainty over Spire’s future direction. (Bloomberg)

Data summarised monthly by Lightyear AI. Last updated on 22 May 2026.

SPI Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

SPI Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Market data provided by London Stock Exchange, through Infront.

Buy £SPI

Capital at risk

Market closed

Upcoming events

Bulls say / Bears say

London’s Spire Healthcare received an unsolicited $1.35 billion buyout proposal from Toscafund, underscoring that the company may be undervalued and could command a takeover premium. (Reuters)

Spire confirmed initial discussions with private equity groups Bridgepoint and Triton, signaling strong interest from the market that could lead to a profitable exit for investors. (Reuters)

Spire warned that adjusted profit for FY25 will be at the low end of guidance, citing a slowdown in NHS commissioning and highlighting challenges in public sector revenues. (Reuters)

FY25 adjusted EBITDA missed market expectations despite revenues meeting forecasts, showing ongoing margin pressure from rising costs. (Reuters)

Shares dropped by up to 21%, reaching their lowest point since March 2021, after preliminary strategic talks ended, highlighting investor uncertainty over Spire’s future direction. (Bloomberg)

Data summarised monthly by Lightyear AI. Last updated on 22 May 2026.

About Spire Healthcare Group

Ticker

Primary listing

Employees

SPI Metrics

Price and volume

Financial strength

Profitability

Management effectiveness

Valuation

Growth

What the Analysts think about SPI

Analyst Ratings

Bulls say / Bears say

SPI Financial Performance

Income Statement

SPI Earnings Performance

Earnings per share (EPS)

Buy £SPI

Upcoming events

Lightyear

Legal

Work with us

Bulls say / Bears say

Spire Healthcare Group/£SPI

About Spire Healthcare Group

Ticker

Primary listing

Employees

SPI Metrics

Price and volume

Financial strength

Profitability

Management effectiveness

Valuation

Growth

What the Analysts think about SPI

Analyst Ratings

Bulls say / Bears say

SPI Financial Performance

Income Statement

SPI Earnings Performance

Earnings per share (EPS)

Buy £SPI

Upcoming events

What’s the current market cap for Spire Healthcare Group stock?

What is the P/E ratio for Spire Healthcare Group stock?

Does Spire Healthcare Group stock pay dividends?

When is the next Spire Healthcare Group dividend payment date?

What is the beta indicator for Spire Healthcare Group?

Bulls say / Bears say